Abstract This investigation analyzes the common chemical features for inhibitors to develop ligand-based pharmacophore models for lipoxygenase inhibitory activity. The present model is based on a dataset of 47 indolizine derivatives that exhibit inhibition against 15-LOX enzyme isolated from soybeans. Pharmacophore models were developed with pharmacophoric features namely: aromatic ring (R) and hydrogen bond acceptor (A). The pharmacophore hypothesis ARRR.5 with R 2 value 0.9451 yields a 3D-QSAR model which is statistically significant and the best pharmacophore hypothesis. External validation is performed to evaluate the robustness of the model and in this study; it was performed on a test set where correlation coefficient between experimental and predicted activity values was found to be 0.8508. The study suggested that pharmacophore modeling approach could be used as a tool for the development of lead structures.
Introduction
15-Lipoxygenase (15-LOX) enzyme is generally found in reticulocytes, eosinophils, macrophages and skin. 1 Role of 15-lipoxygenase in the development of different kinds of ailments like atherosclerosis, atherogenesis, [2] [3] [4] [5] prothrombotic, 6 prostate cancer, 7, 8 colorectal cancer 9 etc has been evaluated by different researchers from time to time. In all these studies, 2-9 authors tried to establish the mechanism behind 15-lipoxygenase role in the development of different diseases. In view of these, it is relevant to design 15-LOX inhibitors with different heterocyclic moieties viz. indole, indolizine, oxazole, quinoline, isoquinoline etc for the treatment of the above mentioned ailments. [10] [11] [12] In the lights of these facts, Gundersen and coworkers 13 synthesized different indolizine derivatives for lipoxygenase inhibitory potential. Table 1 summarizes the 15-LOX inhibitory activity of indolizine derivatives.
Pharmacophore methodology has been used in designing of new chemical entities as well as in lead optimization and multitarget drug design. As per the definition by IUPAC, 14 a pharmacophore model can be defined as 'an ensemble of steric and electronic features that is necessary to ensure the optimal supramolecular interactions with a specific biological target and to trigger (or block) its biological response'. In a review by Yang, 15 author described the implications of pharmacophore modeling in drug discovery while Cruz and co-workers reviewed the finding of 3D-QSAR studies on single site polymerization catalysts. 16 In the present study, PHASE module of Schro¨dinger suite was used to develop 3D-QSAR models on aligning pharmacophore points. 17 The developed hypothesis mainly identifies the most significant structural properties required to judge lipoxygenase inhibitory activity of the indolizine ring.
Experimental

Dataset
To design a pharmacophore model, a set of 47 indolizine derivatives with potent lipoxygenase inhibitory activity was used to develop this pharmacophore model. 13 Indolizine derivatives were screened for their inhibitory activity against 15-lipoxygenases from soybeans and rabbit reticulocytes but due to insufficient data, dataset of 15-lipoxygenases from soybeans was selected for 3D-QSAR study. For ease in calculation, standard deviation for each value was omitted from the chosen dataset. The IC 50 value of each compound was converted into pIC 50 (negative logarithm of IC 50 ). The selected dataset was randomly divided into test (22) and training set (25). Basic structure and their respective substituents used in the study are shown in Fig. 1 and Table 1 , respectively along with their experimental/predicted activity.
Pharmacophore modeling
For the generation of pharmacophore models, PHASE software was used. Maestro algorithm was used to draw the chemical structures of the molecules followed by the application of LigPrep program to produce perfectly chiral and high quality all-atom 3D structures. The structures so obtained were subjected to ionization at pH 7. Conformers of the training set molecules were generated with the Monte Carlo method by OPLS-2005 force field as provided in MacroModel 9.6 2008, then these were minimized using Truncated Newton Conjugate Gradient. 18, 19 Pharmacophoric features viz. aromatic ring (R) and hydrogen bond acceptor (A) were used to generate pharmacophore sites to map all essential chemical features of dataset molecules. Three to six sites were fixed for all the features. Pharmacophore hypotheses and common pharmacophore were created by PHASE, 2008. The regression was carried out on hypotheses with stepwise increasing number of PLS factors. 3D-QSAR models were generated using 25 molecules of training set with 1-3 PLS factors and by fixing grid spacing of 1 Å . Further, common pharmacophore hypotheses were Figure 2 (A) PHASE generated pharmacophore model ARRR.5 illustrating hydrogen bond acceptor (A2; pink), and aromatic rings (R4; R5; R8; orange) features. (B) All ligands overlapped on the generated model ARRR.5. evaluated using survival score to find the best alignment of the active molecules using root mean square deviation value of 1.2 Å . The scoring of hypotheses were performed using default parameters. Survival score secured by each hypothesis, is the measure of the quality of alignment for a particular hypotheses. The stepwise detailed methodology has already been explained. 20 
Validation of pharmacophore model
For the assessment of the best hypotheses, validation needs to be performed wherein the pharmacophore model can be validated for its ability to accurately predict the biological activity or for the identification of the active molecules from the dataset. Among the above two options; the activity prediction of test set was chosen as the validation criteria for the developed pharmacophore model. Briefly, the test molecules were processed using the same development protocol as was used for the training set molecules followed by activity prediction of test molecules employing the pharmacophore model developed in the study. Finally, determination of a prospective correlation between experimental and predicted activities of the test molecules was envisaged.
Results and discussion
Indolizine derivatives are well known for their biological potential viz. antiproliferative, anti-inflammatory, antitubercular, antimicrobial as reviewed by Sharma and Kumar. 10 Ligand-based drug design is an important tool by which a pharmacophore model may be developed that can define minimum structural requirements essential for molecule-target binding.
The pharmacophore model was developed by using twentyfive molecules wherein hydrogen bond acceptor (A) and aromatic rings (R) were employed as pharmacophore features for creating interaction sites. Pharmacophore hypotheses with four features were generated and were evaluated for stringent scoring function analysis. Table 2 depicts the results of four featured pharmacophore hypotheses. ARRR.5 represented the best hypothesis ( Fig. 2) with highest R 2 value of 0.9451, highest Pearson R value of 0.7439 and survival score of 3.094, featuring a hydrogen bond acceptor (A) and aromatic rings (R). Tables 3 and 4 represent the distances and angles respectively between different ARRR.5 sites.
The fitness score for the ligands was calculated by superimposing each ligand on ARRR.5 ( Table 5 ). The fitness score could be helpful in judging the suitability of a model as it measures the distance between the feature and the center of the hypothesis feature while on the other hand, it also evaluates if the feature is mapped or not. 21 The validity of generated pharmacophore model was carried out by performing the activity prediction of training set in addition to the survival score analysis. Therefore, the ARRR.5 model was regressed against the training set. Predicted and experimental 15-LOX inhibitory activities of training set molecules based on ARRR.5 hypothesis are shown in Table 1 . The predicted activities of training set illustrated a correlation of 0.9451 with reported 15-lipoxygenase inhibitory activity using the ARRR.5 model (Fig. 3A) . The validity and predictive character of ARRR.5 was done by prediction profiling of the test set with 22 molecules. Similar to training set; the test set was orderly built and minimized before carrying out the conformational analysis. Subsequently, biological activities of the test set were predicted with the help of ARRR.5 model and furthermore compared with the experimental 15-LOX inhibitory activity. Table 1 corresponds to the predicted and experimental activity (pIC 50 ) values of the test as well as training set molecules with a close correlation value of 0.8508 for test set molecules (Fig. 3B ). Goyal and co-workers proposed that a reliable model can be duly constructed if squared predictive correlation coefficient is more than 0.60. 22 In accordance with this observation; the ARRR.5 model could be used for the prediction of 15-LOX inhibitory activity.
Conclusion
In this study, ARRR.5 pharmacophore model was created using indolizine derivatives acting as 15-LOX inhibitors. Hypothesis ARRR.5 might be considered as the best pharmacophore model as it displayed a good regression coefficient value of 0.9451, Pearson R 0.7439 and survival score 3.094. It consisted of three aromatic rings (R) and one hydrogen bond acceptor (A). A good correlation between experimental and predicted activity of the training (R 2 = 0.9473) and test (R 2 = 0.8508) set molecules was displayed by ARRR.5 model. In accordance with the above results, 15-LOX inhibitory activity was precisely predicted by ARRR.5 model. Validation further supports the appropriateness of ARRR.5 model. At last, it might be concluded that ARRR.5 model could be an appropriate tool for the designing of new 15-LOX inhibitors.
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